IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | 969 hari yang lalu
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | 520 hari yang lalu
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | 703 hari yang lalu
ECB Leaves Rates Unchanged As Expected

ECB Leaves Rates Unchanged As Expected

The European Central Bank held its key interest rates steady on Thursday, in line with expectations, as policymakers assessed that price pressures continue to ease, but acknowledged that the economic environment remains highly uncertain mainly due to the trade tariff wars.
RTTNews | 11 minit yang lalu
UK Private Sector Growth Moderates On Services Activity

UK Private Sector Growth Moderates On Services Activity

UK private sector output continued to grow in July but the pace of expansion moderated as services activity lost momentum, flash survey results from S&P Global revealed on Thursday. The composite output index slid to 51.0 in July from 52.0 in June. The reading was also above the forecast of 51.9.
RTTNews | 52 minit yang lalu
Bay Street Likely To Open On Mixed Note; Trade Talks, Earnings In Focus

Bay Street Likely To Open On Mixed Note; Trade Talks, Earnings In Focus

Canadian shares are likely to open on a mixed note Thursday morning with investors focusing on trade talks between Canadian and U.S. officials, and reacting to the latest batch of economic data. The focus will also be on U.S. President Donald Trump's visit to the Federal Reserve today. Ahead of next week's policy meeting of the Fed, the visit looks significant.
RTTNews | 1j 22min yang lalu
Eurozone Private Sector Growth At 11-Month High

Eurozone Private Sector Growth At 11-Month High

The euro area private sector grew at the fastest pace in almost a year in July as the recession in the manufacturing sector is coming to an end, flash survey results from S&P Global revealed Thursday. The HCOB composite output index posted 51.0 in July, up from 50.6 in the previous month. A score above 50.0 signals expansion.
RTTNews | 1j 26min yang lalu
Honeywell Lifts FY25 Outlook Above Markt After Q2 Beats Street

Honeywell Lifts FY25 Outlook Above Markt After Q2 Beats Street

Honeywell International Inc. (HON), which is preparing to separate into three public companies, on Thursday lifted its fiscal 2025 outlook for earnings and revenues after reporting higher second-quarter results above market estimates. In pre-market activity on the Nasdaq, Honeywell shares were losing around 1.4 percent.
RTTNews | 2j 47min yang lalu
FTSE 100 Up Nearly 1% On Encouraging Earnings Updates

FTSE 100 Up Nearly 1% On Encouraging Earnings Updates

U.K. stocks are up firmly in positive territory Thursday morning amid easing concerns about trade, as the U.S. and EU appear set to strike a deal sometime soon. Investors are also reacting to earnings updates and the latest batch of regional economic data.
RTTNews | 3j 21min yang lalu